T1	LIVB 21 26	Mujer
#1	AnnotatorNotes T1	C0043210; Woman; Population Group | C0242665; wife; Family Group
T2	Age 30 37	70 años
T3	PROC 50 58	consulta
#2	AnnotatorNotes T3	C0009818; Consultation; Health Care Activity
T4	PROC 62 79	Atención Primaria
#3	AnnotatorNotes T4	C0033137; Primary Health Care; Health Care Activity
T5	PROC 85 105	analítica de control
T6	Frequency 106 111	anual
T7	DISO 161 182	Hipertensión arterial
#4	AnnotatorNotes T7	C0020538; Hypertensive disease; Disease or Syndrome
T8	PROC 186 197	tratamiento
#5	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	CHEM 202 210	Losartán
#6	AnnotatorNotes T9	C0126174; losartan; Organic Chemical · Pharmacologic Substance
T10	Dose 211 216	100mg
T11	CHEM 217 234	Hidroclorotiazida
#7	AnnotatorNotes T11	C0020261; hydrochlorothiazide; Organic Chemical · Pharmacologic Substance
T12	Dose 235 239	25mg
T13	Frequency 240 248	cada 24h
T14	CHEM 251 261	Amlodipino
#8	AnnotatorNotes T14	C0051696; amlodipine; Organic Chemical · Pharmacologic Substance
T15	Dose 262 265	5mg
T16	Frequency 266 274	cada 12h
T17	DISO 276 286	Dislipemia
#9	AnnotatorNotes T17	C0242339; Dyslipidemias; Disease or Syndrome
T18	PROC 288 299	Seguimiento
#10	AnnotatorNotes T18	C0420316; Other follow-up; Health Care Activity
T19	DISO 314 331	patología crónica
T20	Duration 324 331	crónica
T21	DISO 355 367	Leucocitosis
#11	AnnotatorNotes T21	C0023518; Leukocytosis; Disease or Syndrome | C0750426; White blood cell count increased (lab result); Finding
T22	Date 371 388	noviembre de 2018
T23	Spec_cue 389 401	posiblemente
T24	Speculated 405 440	relación con un problema infeccioso
T25	DISO 421 440	problema infeccioso
T26	Neg_cue 473 476	sin
T27	LIVB 477 482	hijos
T28	Negated 477 482	hijos
T29	PROC 486 492	EXAMEN
#12	AnnotatorNotes T29	C0031809; Physical Examination; Health Care Activity
T30	PROC 495 513	Exploración física
#13	AnnotatorNotes T30	C0031809; Physical Examination; Health Care Activity
T31	PHYS 536 546	consciente
#14	AnnotatorNotes T31	C0229994; Conscious mind; Mental Process | C0234421; Conscious; Mental Process
T32	PHYS 548 557	orientada
T33	Neg_cue 644 647	Sin
T34	DISO 648 654	signos
#15	AnnotatorNotes T34	C0311392; Physical findings; Finding
T35	Negated 648 679	signos de focalidad neurológica
T36	DISO 658 679	focalidad neurológica
#16	AnnotatorNotes T36	C1848821; Focal neurologic signs; Finding
T37	PROC 682 685	ACR
#17	AnnotatorNotes T37	C0584615; Urine microalbumin/creatinine ratio measurement; Laboratory Procedure
T38	Neg_cue 711 714	sin
T39	DISO 715 721	soplos
#18	AnnotatorNotes T39	C0006318; Bruit; Finding | C0018808; Heart murmur; Finding | C0232255; Innocent Murmurs; Finding
T40	Negated 715 721	soplos
T41	Neg_cue 754 757	sin
T42	DISO 758 790	ruidos patológicos sobreañadidos
T43	Negated 758 790	ruidos patológicos sobreañadidos
T44	Neg_cue 792 794	No
T45	DISO 795 801	edemas
#19	AnnotatorNotes T45	C0013604; Edema; Pathologic Function
T46	Negated 795 801	edemas
T47	Neg_cue 802 804	ni
T48	DISO 805 811	signos
#20	AnnotatorNotes T48	C0311392; Physical findings; Finding
T49	Negated 805 863	signos de trombosis venosa profunda en miembros inferiores
T50	DISO 815 840	trombosis venosa profunda
#21	AnnotatorNotes T50	C0149871; Deep Vein Thrombosis; Disease or Syndrome
T51	ANAT 844 863	miembros inferiores
#22	AnnotatorNotes T51	C0023216; Lower Extremity; Body Part, Organ, or Organ Component | C1269079; Entire lower limb; Body Part, Organ, or Organ Component
T52	PROC 866 889	Pruebas Complementarias
#23	AnnotatorNotes T52	C1515980; Ancillary Study; Research Activity
T53	PROC 891 900	Analítica
#24	AnnotatorNotes T53	C0002778; Analysis of substances; Laboratory Procedure
T54	PROC 902 911	Hemograma
#25	AnnotatorNotes T54	C0009555; Complete Blood Count; Laboratory Procedure | C0200631; Complete blood count without differential; Laboratory Procedure | C0852571; Blood counts NEC; Laboratory Procedure
T55	PROC 913 924	Hemoglobina
#26	AnnotatorNotes T55	C0518015; Hemoglobin measurement; Laboratory Procedure
T56	PROC 927 936	Plaquetas
T57	PROC 947 957	Leucocitos
T58	ANAT 976 986	linfocitos
#27	AnnotatorNotes T58	C0024264; Lymphocyte; Cell
T59	PROC 992 1002	Bioquímica
#28	AnnotatorNotes T59	C0201682; Chemical procedure; Laboratory Procedure | C0430027; biochemical test; Laboratory Procedure
T60	PROC 1004 1015	ácido úrico
#29	AnnotatorNotes T60	C0202239; Uric acid measurement (procedure); Laboratory Procedure
T61	PROC 1026 1036	Creatinina
#30	AnnotatorNotes T61	C0201975; Creatinine measurement; Laboratory Procedure
T62	PROC 1048 1058	Colesterol
#31	AnnotatorNotes T62	C0201950; Cholesterol measurement test; Laboratory Procedure
T63	PROC 1069 1072	HDL
#32	AnnotatorNotes T63	C0392885; High density lipoprotein measurement; Laboratory Procedure
T64	PROC 1082 1085	LDL
#33	AnnotatorNotes T64	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T65	Neg_cue 1103 1106	sin
T66	Negated 1107 1127	hallazgos relevantes
T67	PROC 1158 1169	consulta de
T68	PROC 1170 1187	Atención Primaria
#34	AnnotatorNotes T68	C0033137; Primary Health Care; Health Care Activity
T69	PROC 1209 1218	analítica
#35	AnnotatorNotes T69	C0002778; Analysis of substances; Laboratory Procedure
T70	PROC 1230 1256	recomendaciones dietéticas
T71	PROC 1262 1284	control de ácido úrico
T72	PROC 1313 1324	tratamiento
#36	AnnotatorNotes T72	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T73	PROC 1358 1385	frotis de sangre periférica
#37	AnnotatorNotes T73	C2238079; blood smear; Laboratory Procedure
T74	Spec_cue 1401 1408	posible
T75	Speculated 1409 1430	causa de linfocitosis
T76	DISO 1418 1430	linfocitosis
#38	AnnotatorNotes T76	C0024282; Lymphocytosis; Disease or Syndrome | C0853698; Lymphocyte count increased; Finding
T77	PROC 1482 1488	frotis
#39	AnnotatorNotes T77	C0444186; Smear test; Diagnostic Procedure
T78	PROC 1496 1513	Atención Primaria
#40	AnnotatorNotes T78	C0033137; Primary Health Care; Health Care Activity
T79	PROC 1565 1573	consulta
#41	AnnotatorNotes T79	C0009818; Consultation; Health Care Activity
T80	PROC 1657 1666	Analítica
#42	AnnotatorNotes T80	C0002778; Analysis of substances; Laboratory Procedure
T81	PROC 1668 1677	Hemograma
#43	AnnotatorNotes T81	C0009555; Complete Blood Count; Laboratory Procedure | C0200631; Complete blood count without differential; Laboratory Procedure | C0852571; Blood counts NEC; Laboratory Procedure
T82	PROC 1679 1690	Hemoglobina
#44	AnnotatorNotes T82	C0518015; Hemoglobin measurement; Laboratory Procedure
T83	PROC 1693 1702	Plaquetas
T84	PROC 1713 1723	Leucocitos
T85	ANAT 1742 1752	linfocitos
#45	AnnotatorNotes T85	C0024264; Lymphocyte; Cell
T86	PROC 1758 1768	Bioquímica
#46	AnnotatorNotes T86	C0201682; Chemical procedure; Laboratory Procedure | C0430027; biochemical test; Laboratory Procedure
T87	PROC 1770 1781	ácido úrico
#47	AnnotatorNotes T87	C0202239; Uric acid measurement (procedure); Laboratory Procedure
T88	PROC 1792 1802	Creatinina
#48	AnnotatorNotes T88	C0201975; Creatinine measurement; Laboratory Procedure
T89	PROC 1814 1817	LDH
#49	AnnotatorNotes T89	C0202113; Lactate dehydrogenase measurement; Laboratory Procedure
T90	PROC 1826 1843	β2 Microglobulina
#50	AnnotatorNotes T90	C0201910; Beta-2-microglobulin measurement; Laboratory Procedure
T91	PROC 1855 1879	Inmunoglobulinas A, G, M
T92	PROC 1890 1901	Ac VHB core
T93	Neg_cue 1918 1921	sin
T94	Negated 1922 1942	hallazgos relevantes
T95	PROC 1946 1965	Citometría de flujo
#51	AnnotatorNotes T95	C0016263; Flow Cytometry; Laboratory Procedure
T96	DISO 1983 2018	Síndrome Linfoproliferativo crónico
#52	AnnotatorNotes T96	C0344462; Chronic lymphoproliferative disease NOS; Neoplastic Process
T97	Duration 2011 2018	crónico
T98	PROC 2026 2040	inmunofenotipo
T99	Spec_cue 2041 2055	compatible con
T100	DISO 2056 2086	Neoplasia de Células B maduras
T101	Speculated 2056 2086	Neoplasia de Células B maduras
T102	Spec_cue 2087 2099	sugestivo de
T103	DISO 2100 2134	Linfoma no Hodgkin (LNH) Folicular
T104	Speculated 2100 2134	Linfoma no Hodgkin (LNH) Folicular
T105	Spec_cue 2135 2156	sin poder descartarse
T106	DISO 2157 2168	LNH Burkitt
T107	Speculated 2157 2168	LNH Burkitt
T108	DISO 2171 2202	LNH Difuso de células grandes B
T109	Speculated 2171 2203	LNH Difuso de células grandes B.
T110	PROC 2206 2209	TAC
#53	AnnotatorNotes T110	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T111	DISO 2231 2254	paniculitis mesentérica
#54	AnnotatorNotes T111	C0267770; Retractile Mesenteritis; Disease or Syndrome
T112	Neg_cue 2256 2259	sin
T113	DISO 2260 2271	adenopatías
#55	AnnotatorNotes T113	C0497156; Lymphadenopathy; Disease or Syndrome | C4282165; Swollen Lymph Node; Sign or Symptom
T114	Negated 2260 2271	adenopatías
T115	Neg_cue 2272 2274	ni
T116	DISO 2275 2283	megalias
T117	Negated 2275 2283	megalias
T118	PROC 2287 2309	Biopsia de médula ósea
T119	DISO 2333 2356	Linfoma B de bajo grado
#56	AnnotatorNotes T119	C0456861; Low grade B-cell lymphoma; Neoplastic Process
T120	DISO 2384 2407	Linfoma B de bajo grado
#57	AnnotatorNotes T120	C0456861; Low grade B-cell lymphoma; Neoplastic Process
T121	PROC 2411 2422	TRATAMIENTO
#58	AnnotatorNotes T121	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T122	DISO 2433 2448	asintomatología
T123	Neg_cue 2453 2464	ausencia de
T124	DISO 2465 2475	síntomas B
T125	Negated 2465 2475	síntomas B
T126	DISO 2481 2492	adenopatías
#59	AnnotatorNotes T126	C0497156; Lymphadenopathy; Disease or Syndrome | C4282165; Swollen Lymph Node; Sign or Symptom
T127	Negated 2481 2492	adenopatías
T128	PROC 2504 2526	abstención terapéutica
T129	Neg_cue 2504 2514	abstención
T130	Negated 2515 2526	terapéutica
T131	PROC 2531 2538	control
#60	AnnotatorNotes T131	C1522577; follow-up; Health Care Activity
T132	PROC 2541 2552	seguimiento
#61	AnnotatorNotes T132	C0420316; Other follow-up; Health Care Activity
